PT-141 Melanocortin Receptor Pharmacology Research
Research methodology for characterizing PT-141 at MC3R and MC4R receptors and downstream signaling in cell line and tissue studies.
Read Article
Neuropeptide Research
Semax and BDNF Research: Cognitive and Neurotrophin Signaling Studies
Research methodology for investigating Semax effects on BDNF expression, cognitive task performance, and neurotrophin signaling in rodent models.
Read Article
Semax (ACTH 4-7 Heptapeptide Analog): Complete Research Applications Guide (2026)
Semax is a synthetic heptapeptide corresponding to ACTH(4-7) with a C-terminal Pro-Gly-Pro tripeptide extension for enzymatic stability. Developed at the Russian Academy of Medical Sciences,...
Read Article
PT-141 (Bremelanotide, Melanocortin Analog): Complete Research Applications Guide (2026)
PT-141 (Bremelanotide) is a cyclic heptapeptide melanocortin receptor agonist with selectivity for MC3R and MC4R subtypes. Originally developed from alpha-MSH, it received FDA approval in...
Read Article
All products are sold strictly for in vitro research and laboratory use. Not for human consumption, therapeutic use, or veterinary use. No statements on this website have been evaluated by the FDA. Products are not intended to diagnose, treat, cure, or prevent any disease. By purchasing, you confirm you are a qualified researcher and agree to our Terms of Service. CA Prop 65 Warning: Products may contain chemicals known to the State of California to cause cancer or reproductive harm.
